These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
230 related articles for article (PubMed ID: 26516926)
21. Development of cystic glandular hyperplasia of the endometrium in Mullerian inhibitory substance type II receptor-pituitary tumor transforming gene transgenic mice. El-Naggar SM; Malik MT; Martin A; Moore JP; Proctor M; Hamid T; Kakar SS J Endocrinol; 2007 Jul; 194(1):179-91. PubMed ID: 17592032 [TBL] [Abstract][Full Text] [Related]
22. Overexpression of pituitary tumor transforming gene (PTTG) is associated with tumor progression and poor prognosis in patients with esophageal squamous cell carcinoma. Zhang J; Yang Y; Chen L; Zheng D; Ma J Acta Histochem; 2014 Apr; 116(3):435-9. PubMed ID: 24176776 [TBL] [Abstract][Full Text] [Related]
23. PTTG acts as a STAT3 target gene for colorectal cancer cell growth and motility. Zhou C; Tong Y; Wawrowsky K; Melmed S Oncogene; 2014 Feb; 33(7):851-61. PubMed ID: 23416975 [TBL] [Abstract][Full Text] [Related]
24. Expression of cell cycle regulators and biomarkers of proliferation and regrowth in human pituitary adenomas. Gruppetta M; Formosa R; Falzon S; Ariff Scicluna S; Falzon E; Degeatano J; Vassallo J Pituitary; 2017 Jun; 20(3):358-371. PubMed ID: 28342098 [TBL] [Abstract][Full Text] [Related]
26. Calcium-sensing receptor induces messenger ribonucleic acid of human securin, pituitary tumor transforming gene, in rat testicular cancer. Tfelt-Hansen J; Schwarz P; Terwilliger EF; Brown EM; Chattopadhyay N Endocrinology; 2003 Dec; 144(12):5188-93. PubMed ID: 12970167 [TBL] [Abstract][Full Text] [Related]
27. Effects of silencing PTTG expression by small interference RNA. Zhang SX; Shan WX; Yuan LP; Liu YL; Sun LZ Eur Rev Med Pharmacol Sci; 2016 Jul; 20(13):2835-41. PubMed ID: 27424983 [TBL] [Abstract][Full Text] [Related]
28. Pituitary tumor transforming gene (PTTG) stimulates thyroid cell proliferation via a vascular endothelial growth factor/kinase insert domain receptor/inhibitor of DNA binding-3 autocrine pathway. Kim DS; Franklyn JA; Boelaert K; Eggo MC; Watkinson JC; McCabe CJ J Clin Endocrinol Metab; 2006 Nov; 91(11):4603-11. PubMed ID: 16926250 [TBL] [Abstract][Full Text] [Related]
29. Her4 promotes cancer metabolic reprogramming via the c-Myc-dependent signaling axis. Han J; Zhang Y; Xu J; Zhang T; Wang H; Wang Z; Jiang Y; Zhou L; Yang M; Hua Y; Cai Z Cancer Lett; 2021 Jan; 496():57-71. PubMed ID: 33038488 [TBL] [Abstract][Full Text] [Related]
30. KPNA2 promotes metabolic reprogramming in glioblastomas by regulation of c-myc. Li J; Liu Q; Liu Z; Xia Q; Zhang Z; Zhang R; Gao T; Gu G; Wang Y; Wang D; Chen X; Yang Y; He D; Xin T J Exp Clin Cancer Res; 2018 Aug; 37(1):194. PubMed ID: 30115078 [TBL] [Abstract][Full Text] [Related]
31. Metabolic reprogramming of metastatic breast cancer and melanoma by let-7a microRNA. Serguienko A; Grad I; Wennerstrøm AB; Meza-Zepeda LA; Thiede B; Stratford EW; Myklebost O; Munthe E Oncotarget; 2015 Feb; 6(4):2451-65. PubMed ID: 25669981 [TBL] [Abstract][Full Text] [Related]
32. ACTL6A regulates follicle-stimulating hormone-driven glycolysis in ovarian cancer cells via PGK1. Zhang J; Zhang J; Wei Y; Li Q; Wang Q Cell Death Dis; 2019 Oct; 10(11):811. PubMed ID: 31649264 [TBL] [Abstract][Full Text] [Related]
33. Proteasome activator subunit 3 promotes pancreatic cancer growth via c-Myc-glycolysis signaling axis. Guo J; Hao J; Jiang H; Jin J; Wu H; Jin Z; Li Z Cancer Lett; 2017 Feb; 386():161-167. PubMed ID: 27756569 [TBL] [Abstract][Full Text] [Related]
34. The pituitary tumor-transforming gene promotes angiogenesis in a mouse model of follicular thyroid cancer. Kim CS; Ying H; Willingham MC; Cheng SY Carcinogenesis; 2007 May; 28(5):932-9. PubMed ID: 17127711 [TBL] [Abstract][Full Text] [Related]
35. EZH2 supports ovarian carcinoma cell invasion and/or metastasis via regulation of TGF-beta1 and is a predictor of outcome in ovarian carcinoma patients. Rao ZY; Cai MY; Yang GF; He LR; Mai SJ; Hua WF; Liao YJ; Deng HX; Chen YC; Guan XY; Zeng YX; Kung HF; Xie D Carcinogenesis; 2010 Sep; 31(9):1576-83. PubMed ID: 20668008 [TBL] [Abstract][Full Text] [Related]
36. Differential functions of growth factor receptor-bound protein 7 (GRB7) and its variant GRB7v in ovarian carcinogenesis. Wang Y; Chan DW; Liu VW; Chiu P; Ngan HY Clin Cancer Res; 2010 May; 16(9):2529-39. PubMed ID: 20388850 [TBL] [Abstract][Full Text] [Related]
37. Mitochondrial p32 is upregulated in Myc expressing brain cancers and mediates glutamine addiction. Fogal V; Babic I; Chao Y; Pastorino S; Mukthavaram R; Jiang P; Cho YJ; Pingle SC; Crawford JR; Piccioni DE; Kesari S Oncotarget; 2015 Jan; 6(2):1157-70. PubMed ID: 25528767 [TBL] [Abstract][Full Text] [Related]
38. Overexpression of HE4 (human epididymis protein 4) enhances proliferation, invasion and metastasis of ovarian cancer. Zhu L; Zhuang H; Wang H; Tan M; Schwab CL; Deng L; Gao J; Hao Y; Li X; Gao S; Liu J; Lin B Oncotarget; 2016 Jan; 7(1):729-44. PubMed ID: 26575020 [TBL] [Abstract][Full Text] [Related]
39. Small interfering RNA against PTTG: a novel therapy for ovarian cancer. El-Naggar SM; Malik MT; Kakar SS Int J Oncol; 2007 Jul; 31(1):137-43. PubMed ID: 17549414 [TBL] [Abstract][Full Text] [Related]
40. Nutrient deprivation-related OXPHOS/glycolysis interconversion via HIF-1α/C-MYC pathway in U251 cells. Liu Z; Sun Y; Tan S; Liu L; Hu S; Huo H; Li M; Cui Q; Yu M Tumour Biol; 2016 May; 37(5):6661-71. PubMed ID: 26646563 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]